Kidney biopsies after liver transplant for new kidney problems
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies kidney biopsies in people who had a liver transplant and then developed new signs of kidney damage. The goal is to better understand what’s causing the problem and how to guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You had a liver transplant in the past
- In the last period, you developed new kidney issues such as high urine protein (or worsening kidney function), like eGFR below 60 on two checks, or creatinine rising by at least 50%
- You had a kidney (renal) biopsy within the last 3 months
- You can sign the informed consent form
- You have not had a kidney transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This study looks at how the kidneys are affected during a liver transplant in people with hepatorenal syndrome. It uses a small kidney sample (biopsy) taken during the transplant to understand changes.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.